Reisberg et al developed the Global Deterioration Scale (GDS) to stage the progression of dementia in a patient. The authors are from the New York Medical Center.
NOTE: The GDS is used in conjunction with the FAST of Reisberg (see Chapter 37) to assess impairment.
Scale |
Cognitive Decline |
Clinical Findings |
---|---|---|
1 |
none |
normal cognitive function |
2 |
very mild (minimal) |
overlaps with age-related memory decline; may misplace things or forgets some names |
3 |
mild |
decreased work performance; may get lost when going to an unfamiliar place; some decrease in memory and concentration; deficits can be detected on detailed testing |
4 |
moderate |
needs assistance with complex tasks; obvious deficits in memory and concentration; may have problems when traveling |
5 |
moderate to severe |
needs assistance in choosing clothes to wear and some other activities; may be unable to recall important information |
6 |
severe |
needs assistance in most activities, may not recognize spouse or familiar family members at times, still remembers own name |
7 |
very severe (extreme) |
speech lost; may be unable to walk; completely dependent in activities of daily living, unable to remember own name |
One variation of the scale has a stage between very mild and mild disease, termed "early Alzheimer's disease."
Purpose: To classify a patient's level of cognitive functioning using the Global Deterioration Scale (GDS) of Reisberg et al.
Specialty: Neurology
Objective: severity, prognosis, stage
ICD-10: F00,